Reduced IGF-1 levels have previously been associated with an increased risk of ROP onset and progression, suggesting that the analysis of transaminases and other hepatic parameters may provide relevant insights into the complex relationship between neonatal metabolic status and susceptibility to disease development [34,56,57]. This evidence concerns the gene IGF1 and retinopathy of prematurity.